Delivery Order SPE2DB20D1109-SPE2DB22FP14K
Award Date
5/3/22
Potential Completion Date
5/4/22
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Vyvanse 20 mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $2,586.06 and has a completion date of December 3, 2021. The contract is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the DLA Troop Support Medical,...
This federal contract award is for the delivery of Vyvanse 50 mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,231.10, is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary...
This federal contract award is for the delivery of Vyvanse 20 mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,688.04, is a delivery order awarded under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999 and runs through November 2026. This IDC serves as the primary...
This federal contract award is for the delivery of Vyvanse 50 mg capsules to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,402.14, is a delivery order placed under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for...
This federal contract award is for the delivery of Vyvanse 50 mg capsules to the U.S. government. The $1,116.46 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of...
This federal contract award is for the delivery of Vyvanse 20 mg capsules to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,337.70 and is a firm fixed-price delivery order with a completion date of February 5, 2025. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award is for the delivery of Vyvanse 50 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,372.34, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a broader Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award is for the delivery of Vyvanse 20 mg capsules (100 count) to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The award, valued at $1,903.54, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 20, 2021. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of Vyvanse 30 mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,010.59 and an ultimate completion date of November 15, 2023. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is a subsidiary...
This federal contract award is for the delivery of Vyvanse 40 mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which is a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $2,357.61 and an ultimate completion date of May 12, 2022. It is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite...